|
|
|
|
|
|
Abbvie Inc (ABBV)
|
|
87.48 +0.07 (+0.08%)
|
9/22/2017 4:00pm
|
|
Open:
|
87.22
|
Pre. Close:
|
87.41
|
|
High:
|
87.75
|
Low:
|
86.77
|
|
Volume:
|
6,806,950
|
Market Cap:
|
139.45B
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
87.71 - 88.75
|
88.75 - 89.79
|
|
Low:
|
84.86 - 85.7
|
85.7 - 86.54
|
|
Close:
|
86.12 - 87.44
|
87.44 - 88.76
|
|
|
|
|
|
|
Technical analysis (as of: 2017-09-22 4:36:29 PM)
|
|
Overall:
|
 
|
|
Stoxline posted a BUY today, upgraded from lower rating. This stock seems to be ready for a new bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, a new upward move is expected.
|
|
Target:
|
Six months: 104.76 One year: 122.36
|
|
Support:
|
Support1: 77.19 Support2: 69.47
|
|
Resistance:
|
Resistance1:
89.69 Resistance2: 104.76
|
|
Pivot:
|
84.58
|
|
Moving Averages:
|
MA(5): 86.80 MA(20): 81.88
MA(100): 72.34 MA(250): 66.38
|
|
MACD:
|
MACD(12,26):
3.97  Signal(12,26,9): 3.76
|
|
%K %D:
|
%K(14,3): 85.54 %D(3): 83.23
|
|
RSI:
|
RSI(14): 74.57
|
|
52-Week:
|
High: 89.69
Low: 55.06 Change(%): 36.5
|
|
Average Vol(K):
|
3-Month: 500268
10-Days 438670
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.ABBV has closed below upper band by 34.4%. Bollinger Bands are 210.3% wider than normal. The large width of the bands suggest high volatility as compared to ABBV's normal range. The bands have been in this wide range for 16 bars. This is a sign that the current trend might continue.
|
|
|
Headline News
|
|
Tue, 19 Sep 2017 18:33:45 GMT
AbbVie Joins $30 Million Financing Round For Disarm Therapeutics
Fri, 08 Sep 2017 11:15:00 GMT
The case for GlaxoSmithKline
Thu, 14 Sep 2017 17:37:30 GMT
AbbVie: Bullish Institutional Buying To Send The Stock Higher
Sun, 27 Aug 2017 18:00:00 GMT
Returning the love
Wed, 13 Sep 2017 06:22:30 GMT
Market Finally Realizing AbbVie's Value
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
